Shi T - Search Results

1

Increased cellular accumulation and distribution of amrubicin contribute to its activity in anthracycline-resistant cancer cells.

Mamidipudi V, Shi T, Brady H, Surapaneni S, Chopra R, Aukerman SL, Heise C, Sung V. Mamidipudi V, et al. Among authors: shi t. Cancer Chemother Pharmacol. 2012 Apr;69(4):965-76. doi: 10.1007/s00280-011-1782-x. Epub 2011 Nov 26. Cancer Chemother Pharmacol. 2012. PMID: 22120960

2

Pomalidomide in combination with dexamethasone results in synergistic anti-tumour responses in pre-clinical models of lenalidomide-resistant multiple myeloma.

Rychak E, Mendy D, Shi T, Ning Y, Leisten J, Lu L, Miller K, Narla RK, Orlowski RZ, Raymon HK, Bjorklund CC, Thakurta A, Gandhi AK, Cathers BE, Chopra R, Daniel TO, Lopez-Girona A. Rychak E, et al. Among authors: shi t. Br J Haematol. 2016 Mar;172(6):889-901. doi: 10.1111/bjh.13905. Epub 2016 Feb 23. Br J Haematol. 2016. PMID: 26914976 Free article.

3

Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients.

Gandhi AK, Shi T, Li M, Jungnelius U, Romano A, Tabernero J, Siena S, Schafer PH, Chopra R. Gandhi AK, et al. Among authors: shi t. PLoS One. 2013 Nov 11;8(11):e80437. doi: 10.1371/journal.pone.0080437. eCollection 2013. PLoS One. 2013. PMID: 24244687 Free PMC article. Clinical Trial.

4

Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G₁-S Checkpoint.

Zhu D, Xu S, Deyanat-Yazdi G, Peng SX, Barnes LA, Narla RK, Tran T, Mikolon D, Ning Y, Shi T, Jiang N, Raymon HK, Riggs JR, Boylan JF. Zhu D, et al. Among authors: shi t. Mol Cancer Ther. 2018 Aug;17(8):1727-1738. doi: 10.1158/1535-7163.MCT-17-1084. Epub 2018 Jun 4. Mol Cancer Ther. 2018. PMID: 29866747

5

CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization.

Mortensen DS, Fultz KE, Xu S, Xu W, Packard G, Khambatta G, Gamez JC, Leisten J, Zhao J, Apuy J, Ghoreishi K, Hickman M, Narla RK, Bissonette R, Richardson S, Peng SX, Perrin-Ninkovic S, Tran T, Shi T, Yang WQ, Tong Z, Cathers BE, Moghaddam MF, Canan SS, Worland P, Sankar S, Raymon HK. Mortensen DS, et al. Among authors: shi t. Mol Cancer Ther. 2015 Jun;14(6):1295-305. doi: 10.1158/1535-7163.MCT-14-1052. Epub 2015 Apr 8. Mol Cancer Ther. 2015. PMID: 25855786

6

Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance.

Aronchik I, Dai Y, Labenski M, Barnes C, Jones T, Qiao L, Beebe L, Malek M, Elis W, Shi T, Mavrommatis K, Bray GL, Filvaroff EH. Aronchik I, et al. Among authors: shi t. Mol Cancer Res. 2019 Feb;17(2):642-654. doi: 10.1158/1541-7786.MCR-17-0554. Epub 2018 Oct 1. Mol Cancer Res. 2019. PMID: 30275173

7

Proposing advancement criteria for efficient DMPK triage of new chemical entities.

Kulkarni A, Riggs J, Phan C, Bai A, Calabrese A, Shi T, Moghaddam MF. Kulkarni A, et al. Among authors: shi t. Future Med Chem. 2014 Feb;6(2):131-9. doi: 10.4155/fmc.13.190. Future Med Chem. 2014. PMID: 24467240

8

Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY).

Oeth P, del Mistro G, Marnellos G, Shi T, van den Boom D. Oeth P, et al. Among authors: shi t. Methods Mol Biol. 2009;578:307-43. doi: 10.1007/978-1-60327-411-1_20. Methods Mol Biol. 2009. PMID: 19768603

9

SwinUNeCCt: bidirectional hash-based agent transformer for cervical cancer MRI image multi-task learning.

Yang C, Tan Z, Wang Y, Bi R, Shi T, Yang J, Huang C, Jiang P, Fu X. Yang C, et al. Among authors: shi t. Sci Rep. 2024 Oct 19;14(1):24621. doi: 10.1038/s41598-024-75544-5. Sci Rep. 2024. PMID: 39427015 Free article.

10

The role of lactylation in plasma cells and its impact on rheumatoid arthritis pathogenesis: insights from single-cell RNA sequencing and machine learning.

Fu W, Wang T, Lu Y, Shi T, Yang Q. Fu W, et al. Among authors: shi t. Front Immunol. 2024 Oct 3;15:1453587. doi: 10.3389/fimmu.2024.1453587. eCollection 2024. Front Immunol. 2024. PMID: 39421742 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,605 results

Search Page